|
**Overview**: Testosterone Stimulation by HCG Panel**Introduction**: The Testosterone Stimulation by HCG Panel is a diagnostic tool designed for hormonal function assessment using serum samples. In India, male hypogonadism (primary/secondary) affects ~10-20 percent of infertile men and aging males, with Leydig cell function testing (HCG stimulation) essential to differentiate testicular vs hypothalamic-pituitary causes. High morbidity from under-testing in rural/low-SES men with infertility, erectile dysfunction, or delayed puberty, limited endocrine labs, delayed testosterone replacement leading to osteoporosis, metabolic syndrome, or prolonged infertility. Per endocrinology practices aligned with ICMR and Endocrine Society of India guidelines, the test employs immunoassay for total testosterone and free testosterone (pre- and post-HCG) over 3â€"5 days with high accuracy, valuable for assessing testicular reserve (rise >2-3 fold normal response). This diagnostic falls under endocrine screening and targets males with low baseline testosterone, infertility, or hypogonadism suspicion, addressing accurate detection to guide testosterone therapy or gonadotropin treatment. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise Leydig cell evaluation and reducing reproductive/metabolic burden. Its serum-based approach ensures reliable dynamic hormone measurement.**Other Names**: Testo HCG Pnl.**FDA Status**: FDA approved, CLIA certified for endocrinology, compliant with 2025 standards.**Historical Milestone**: HCG stimulation test standard for hypogonadism; in India, routine in andrology clinics.**Purpose**: The test assesses 2 parameters including total testosterone to guide hormonal function assessment, evaluate Leydig cell response, inform replacement therapy.**Test Parameters**: 1. Total Testosterone, 2. Free Testosterone.**Pretest Condition**: Fasting 10-12 hours recommended; patients should have hypogonadism suspicion.**Specimen**: 3 mL serum in 1 SST (serial samples pre/post-HCG), transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve hormone integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on libido, infertility, puberty delay.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected hypogonadism including infertility/osteoporosis, benefits of assessment, and minimal discomfort from venipuncture/HCG injection.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret pre/post-HCG response within 3â€"5 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Inadequate testosterone rise post-HCG indicates primary hypogonadism, necessitating specialist input.**Specialist Consultation**: Endocrinologists or andrologists should be consulted for management.**Additional Supporting Tests**: LH/FSH, testicular ultrasound for confirmation.**Test Limitations**: Requires HCG administration; comprehensive approach required.**References**: Indian Journal of Endocrinology 2024, Andrology Studies India 2023. |
